RXi Pharmaceuticals
RXi Pharmaceuticals is a company developing ribonucleic acid interference-based therapeutics founded in 2011.
1
Funding Rounds
$23.6m
Money raised
Funding series
Funding Series Analysis
The company RXi Pharmaceuticals has raised a total of $23.63m in funding over 1 rounds.
Key Insights:
- RXi Pharmaceuticals funding round, March 2013: $23.63m
RXi Pharmaceuticals funding round, March 2013
$23.63m
Industries
RXi Pharmaceuticals is active in the following industries: